investor.sangamo.com/releasedetail.cfm?ReleaseID=241560 -
[Cached Version]
Published on: 7/27/2006
Last Visited: 8/8/2007
In addition to Dr. Gilman, Sangamo's SAB is comprised of a distinguished group of world-renown research and clinical scientists including: Carl Pabo, Ph.D., Chairman of the SAB, Visiting Professor in Systems Biology at the Harvard Medical School, and former Chief Scientific Officer of Sangamo; Judith Campisi, Ph.D., Head, Center for Research in Aging, Division of Life Sciences, Berkeley National Laboratory; Barrie Carter, Ph.D., Executive Vice President and Chief Scientific Officer, Targeted Genetics Corporation; Sir Aaron Klug, O.M., F.R.S., MRC Laboratory of Molecular Biology, Cambridge U.K., Nobel Laureate, Chemistry, Past President, The Royal Society; Gabor M. Rubanyi, M.D., Ph.D., Chief Scientific Officer, Cardium Therapeutics, Inc.; and Kevin Struhl, Ph.D., David Wesley Gaiser Professor of Biological Chemistry, Harvard Medical School.